1.
Nature
; 629(8014): 989-991, 2024 May.
Article
in English
| MEDLINE
| ID: mdl-38811708
2.
Nature
; 628(8007): 248, 2024 Apr.
Article
in English
| MEDLINE
| ID: mdl-38570656
3.
4.
5.
Nature
; 626(7999): 466, 2024 Feb.
Article
in English
| MEDLINE
| ID: mdl-38302704
6.
Nature
; 630(8016): 290-292, 2024 Jun.
Article
in English
| MEDLINE
| ID: mdl-38862759
Subject(s)
Cancer Vaccines , Neoplasms , Precision Medicine , Humans , Cancer Vaccines/immunology , Cancer Vaccines/pharmacology , Cancer Vaccines/therapeutic use , mRNA Vaccines/immunology , mRNA Vaccines/pharmacology , mRNA Vaccines/therapeutic use , Neoplasms/immunology , Neoplasms/prevention & control , Neoplasms/therapy , Precision Medicine/trends , Precision Medicine/methods
7.
8.
Nature
; 626(8001): 1152-1154, 2024 Feb.
Article
in English
| MEDLINE
| ID: mdl-38413751
Subject(s)
Biochemistry , Biophysical Phenomena , Humans , Biochemistry/methods , Biochemistry/trends , Cell Survival , Disease , Health
9.
10.
Nature
; 613(7944): 419-420, 2023 01.
Article
in English
| MEDLINE
| ID: mdl-36639446
Subject(s)
COVID-19 Vaccines , COVID-19 , Clinical Trials as Topic , Drug Design , RNA, Messenger , Vaccine Development , mRNA Vaccines , Humans , COVID-19/prevention & control , COVID-19 Vaccines/chemistry , COVID-19 Vaccines/genetics , RNA, Messenger/chemistry , RNA, Messenger/genetics , mRNA Vaccines/chemistry , mRNA Vaccines/genetics , Vaccine Development/standards , Drug Design/standards
11.
Nature
; 614(7948): 404-406, 2023 02.
Article
in English
| MEDLINE
| ID: mdl-36792744
12.
Nature
; 621(7980): S55-S57, 2023 Sep.
Article
in English
| MEDLINE
| ID: mdl-37758887
Subject(s)
Antibodies, Viral , Infant, Newborn, Diseases , Respiratory Syncytial Virus Infections , Respiratory Syncytial Virus, Human , Humans , Infant , Respiratory Syncytial Virus, Human/drug effects , Respiratory Syncytial Virus, Human/immunology , Respiratory Syncytial Virus Infections/drug therapy , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Virus Infections/prevention & control , Antibodies, Viral/immunology , Antibodies, Viral/therapeutic use , Infant, Newborn, Diseases/drug therapy , Infant, Newborn, Diseases/immunology , Infant, Newborn, Diseases/prevention & control , Respiratory Syncytial Virus Vaccines
13.
Nature
; 622(7981): 22-24, 2023 Oct.
Article
in English
| MEDLINE
| ID: mdl-37794271
Subject(s)
Drug Industry , RNA, Circular , Humans , Drug Industry/methods , Drug Industry/trends , mRNA Vaccines , RNA, Circular/therapeutic use
14.
Nature
; 624(7992): 506, 2023 Dec.
Article
in English
| MEDLINE
| ID: mdl-38093064
Subject(s)
Anti-Obesity Agents , Research Personnel , Humans , Glucagon-Like Peptides , Weight Loss/drug effects
15.
16.
17.
18.
19.
Nature
; 624(7991): 236-237, 2023 Dec.
Article
in English
| MEDLINE
| ID: mdl-38057473
20.